FDA Inspection 1122860 — Biomat USA, Inc

Biomat USA, Inc — FEI 3000215061

The FDA completed an inspection of Biomat USA, Inc on January 9, 2020 in Macon, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 9, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Macon, GA (United States)